Results 201 to 210 of about 14,853 (241)

Repurposing of FDA-Approved Antiviral Drugs Against Monkeypox Virus: Comparative In Vitro Screening and Structure Based In Silico Studies. [PDF]

Pharmaceuticals (Basel)
Moatasim Y, Kutkat O, Gomaa M, Elshaier YAMM, Nabil M, El-Rashedy AA, Roshdy WH, Kayali G, Ali MA, El-Shesheny R.   +9 more
europepmc   +1 more source

Neurological complications of Orthopoxvirus infections: neurotropism and neurovirulence. [PDF]

Brain
Miranzadeh Mahabadi H, Noyce RS, Evans DH, Power C.   +3 more
europepmc   +1 more source

Assessment of Biological Properties of Recombinant Lumpy Skin Disease Viruses with Deletions of Immunomodulatory Genes. [PDF]

Viruses
Issabek A, Bopi A, Kozhabergenov N, Khudaibergenova B, Sultankulova K, Chervyakova O.   +5 more
europepmc   +1 more source

Genome sequence of fowlpox virus from a field outbreak in Bangladesh. [PDF]

Microbiol Resour Announc
Mozumder A, Akter S, Mia R, Hasan SMN, Das A, Tasmin J, Mondal ABMHR, Rahman MS, Bhuiyan MIU, Akter S, Saha S, Hossain MG.   +11 more
europepmc   +1 more source

AI-driven discovery of antiretroviral drug bictegravir and etravirine as inhibitors against monkeypox and related poxviruses. [PDF]

Commun Biol
Wang Y, Ünlü A, Wang X, Çevrim E, Offermans DM, Flesseman MP, Zaeck LM, Wu L, Bijvelds MJC, Sam-Agudu NA, de Vries RD, Raymond K, Li P, Olğaç A, Wang W, Doğan T, Pan Q.   +16 more
europepmc   +1 more source

Vaccinia virus mRNAs containing long 5'-poly(A)-leaders lack a canonical 5'-methylguanosine cap. [PDF]

Nat Commun
Vopálenský V, Sýkora M, Mělková Z, Barvík I, Horáčková K, Mašek T, Pospíšek M.   +6 more
europepmc   +1 more source

Patterns of genomic deletions in monkeypox virus during the 2022 outbreak in the United States. [PDF]

Nat Commun
Gigante CM, McGrath D, Sukkestad S, Zhao H, Peng M, Takakuwa J, Wilkins K, Wicker V, Matheny A, Khan T, Davidson WB, Sheth M, Burgin A, Hand J, Richardson G, Haydel D, Burroughs M, Padilla J, Lee JS, Batra D, Hetrick EE, Howard DT, O'Connell K, Rowell JL, Morrison S, Gillani S, Lee M, Mangla A, Blythe D, Myers R, Kovar L, Seabolt MH, Weigand MR, Satheshkumar PS, McCollum AM, Hutson CL, Li Y.   +36 more
europepmc   +1 more source

Lumpy skin disease virus protein LSDV122 impairs IFN-I receptor complex formation to evade host innate immunity. [PDF]

PLoS Pathog
Sun MY, Cao LB, Wan QL, Li ZZ, Du JZ, Shu HB, Yang YL.   +6 more
europepmc   +1 more source

Viral piracy of host RNA phosphatase DUSP11 by avipoxviruses. [PDF]

PLoS Pathog
Szymanik KH, Rex EA, Pothireddy VR, Gammon DB, Hancks DC, Sullivan CS.   +5 more
europepmc   +1 more source

A poxvirus ankyrin protein LSDV012 inhibits IFIT1 in a host-species-specific manner by compromising its RNA binding ability. [PDF]

PLoS Pathog
Xie S, Fang Y, Liao Z, Cui L, Niu K, Ren S, Zhu J, Wu W, Jing Z, Peng C.   +9 more
europepmc   +1 more source